These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 15868623

  • 21. The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study.
    Salaffi F, Cimmino MA, Malavolta N, Carotti M, Di Matteo L, Scendoni P, Grassi W, Italian Multicentre Osteoporotic Fracture Study Group.
    J Rheumatol; 2007 Jul; 34(7):1551-60. PubMed ID: 17516618
    [Abstract] [Full Text] [Related]

  • 22. Modeling fracture risk using bone density, age, and years since menopause.
    Carroll J, Testa MA, Erat K, LeBoff MS, Fuleihan G el-H.
    Am J Prev Med; 1997 Jul; 13(6):447-52. PubMed ID: 9415791
    [Abstract] [Full Text] [Related]

  • 23. Physical tests for patient selection for bone mineral density measurements in postmenopausal women.
    Kärkkäinen M, Rikkonen T, Kröger H, Sirola J, Tuppurainen M, Salovaara K, Arokoski J, Jurvelin J, Honkanen R, Alhava E.
    Bone; 2009 Apr; 44(4):660-5. PubMed ID: 19138768
    [Abstract] [Full Text] [Related]

  • 24. Prevalence and predictors of fragility fractures in systemic lupus erythematosus.
    Yee CS, Crabtree N, Skan J, Amft N, Bowman S, Situnayake D, Gordon C.
    Ann Rheum Dis; 2005 Jan; 64(1):111-3. PubMed ID: 15608308
    [Abstract] [Full Text] [Related]

  • 25. The impact of oral corticosteroid use on bone mineral density and vertebral fracture.
    Walsh LJ, Lewis SA, Wong CA, Cooper S, Oborne J, Cawte SA, Harrison T, Green DJ, Pringle M, Hubbard R, Tattersfield AE.
    Am J Respir Crit Care Med; 2002 Sep 01; 166(5):691-5. PubMed ID: 12204867
    [Abstract] [Full Text] [Related]

  • 26. Lack of relationships between cumulative methylprednisolone dose and bone mineral density in healthy men and postmenopausal women with chronic low back pain.
    Dubois EF, Wagemans MF, Verdouw BC, Zwinderman AH, Van Boxtel CJ, Dekhuijzen PN, Schweitzer DH.
    Clin Rheumatol; 2003 Feb 01; 22(1):12-7. PubMed ID: 12605311
    [Abstract] [Full Text] [Related]

  • 27. Trabecular bone score improves fracture risk assessment in glucocorticoid-induced osteoporosis.
    Florez H, Hernández-Rodríguez J, Muxi A, Carrasco JL, Prieto-González S, Cid MC, Espinosa G, Gómez-Puerta JA, Monegal A, Guañabens N, Peris P.
    Rheumatology (Oxford); 2020 Jul 01; 59(7):1574-1580. PubMed ID: 31628810
    [Abstract] [Full Text] [Related]

  • 28. Risk of vertebral fractures in men: relationship to mineral density of the vertebral body.
    Resch A, Schneider B, Bernecker P, Battmann A, Wergedal J, Willvonseder R, Resch H.
    AJR Am J Roentgenol; 1995 Jun 01; 164(6):1447-50. PubMed ID: 7754890
    [Abstract] [Full Text] [Related]

  • 29. [Bone mass, bone metabolism, and prevalence of spinal fractures in recipients of allogenic bone marrow transplantation for leukemia].
    Letizia C, Celi M, Iori AP, Verrelli C, Caliumi C, Diacinti D, Arcese W, D'Erasmo E.
    Ann Ital Med Int; 2004 Jun 01; 19(3):175-83. PubMed ID: 15529945
    [Abstract] [Full Text] [Related]

  • 30. Evaluation of risk factors of vertebral fracture in Japanese female patients with glucocorticoid-induced osteoporosis.
    Mori Y, Izumiyama T, Baba K, Mori N, Fujii H, Ishii T, Itoi E.
    J Orthop Surg Res; 2020 Jul 29; 15(1):290. PubMed ID: 32727595
    [Abstract] [Full Text] [Related]

  • 31. Reduced iliac cancellous osteocyte density in patients with osteoporotic vertebral fracture.
    Qiu S, Rao DS, Palnitkar S, Parfitt AM.
    J Bone Miner Res; 2003 Sep 29; 18(9):1657-63. PubMed ID: 12968675
    [Abstract] [Full Text] [Related]

  • 32. High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study.
    Angeli A, Guglielmi G, Dovio A, Capelli G, de Feo D, Giannini S, Giorgino R, Moro L, Giustina A.
    Bone; 2006 Aug 29; 39(2):253-9. PubMed ID: 16574519
    [Abstract] [Full Text] [Related]

  • 33. Assessing the risk of vertebral osteoporosis.
    Kanis JA.
    Singapore Med J; 2002 Feb 29; 43(2):100-5. PubMed ID: 11993900
    [Abstract] [Full Text] [Related]

  • 34. Corticosteroids do not alter the threshold for vertebral fracture.
    Selby PL, Halsey JP, Adams KR, Klimiuk P, Knight SM, Pal B, Stewart IM, Swinson DR.
    J Bone Miner Res; 2000 May 29; 15(5):952-6. PubMed ID: 10804026
    [Abstract] [Full Text] [Related]

  • 35. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis.
    van Staa TP, Leufkens HG, Cooper C.
    Osteoporos Int; 2002 Oct 29; 13(10):777-87. PubMed ID: 12378366
    [Abstract] [Full Text] [Related]

  • 36. Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials.
    Amiche MA, Albaum JM, Tadrous M, Pechlivanoglou P, Lévesque LE, Adachi JD, Cadarette SM.
    Osteoporos Int; 2016 May 29; 27(5):1709-18. PubMed ID: 26694595
    [Abstract] [Full Text] [Related]

  • 37. Osteoporotic vertebral fracture in clinical practice. 669 Patients diagnosed over a 10 year period.
    Nolla JM, Gómez-Vaquero C, Romera M, Roig-Vilaseca D, Rozadilla A, Mateo L, Fiter J, Juanola X, Rodríguez-Moreno J, Valverde J, Roig-Escofet D.
    J Rheumatol; 2001 Oct 29; 28(10):2289-93. PubMed ID: 11669171
    [Abstract] [Full Text] [Related]

  • 38. Effect of inhaled glucocorticoids and beta(2) agonists on vertebral fracture risk in COPD patients: the EOLO study.
    Gonnelli S, Caffarelli C, Maggi S, Guglielmi G, Siviero P, Rossi S, Crepaldi G, Nuti R, EOLO study group.
    Calcif Tissue Int; 2010 Aug 29; 87(2):137-43. PubMed ID: 20567964
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.